Sulfoximines from a Medicinal Chemist's Perspective: Physicochemical and in vitro Parameters Relevant for Drug Discovery.

Eur J Med Chem

Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Straße 65, 88397 Biberach an der Riß, Germany. Electronic address:

Published: January 2017

Sulfoximines, sulfondiimides and sulfonimidamides are fascinating but not yet fully explored variants of the common sulfone or sulfonamide motif. In this study, we report the physicochemical and in vitro properties of sulfoximines and compare them with related analogs and isosteres. Furthermore, we present a matched molecular pair analysis of compounds from drug discovery projects within Boehringer Ingelheim. We demonstrate that the sulfoximine moiety is a chemically stable, comparatively polar and weakly basic functional group, often leading to favorable aqueous solubility, permeability and metabolic stability. Moreover, their additional vectors at nitrogen enable simple chemical modifications and thus facilitate exploration and fine-tuning of the molecular properties. We conclude that sulfoximines and their congeners do not exhibit any intrinsic flaw but significantly enrich the toolbox of medicinal chemists.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmech.2016.09.091DOI Listing

Publication Analysis

Top Keywords

physicochemical in vitro
8
drug discovery
8
sulfoximines
4
sulfoximines medicinal
4
medicinal chemist's
4
chemist's perspective
4
perspective physicochemical
4
in vitro parameters
4
parameters relevant
4
relevant drug
4

Similar Publications

Article Synopsis
  • Pancreatic cancer features a dense tissue environment that hinders effective delivery of the chemotherapy drug gemcitabine, making treatment challenging.
  • A targeted drug delivery system was developed using gold nanoparticles and the anti-EGFR antibody cetuximab, combined with gemcitabine and polyethylene glycol to enhance drug delivery to pancreatic cancer and associated cells.
  • The new drug delivery system, particularly the PEGylated nanoconjugate ACG44P1000, showed improved effectiveness in reducing the viability of pancreatic cancer cells in lab tests, setting the stage for future studies on its potential to combat tumor growth and desmoplasia in living organisms.*
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!